Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002;91:899-906
Published online before print October 24, 2002, doi: 10.1161/01.RES.0000042703.39845.B4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
91/10/899    most recent
01.RES.0000042703.39845.B4v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eyries, M.
Right arrow Articles by Soubrier, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eyries, M.
Right arrow Articles by Soubrier, F.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Physiological and pathological control of gene expression
(Circulation Research. 2002;91:899.)
© 2002 American Heart Association, Inc.


Molecular Medicine

Phorbol Ester Induction of Angiotensin-Converting Enzyme Transcription Is Mediated by Egr-1 and AP-1 in Human Endothelial Cells via ERK1/2 Pathway

Mélanie Eyries, Monique Agrapart, Amalia Alonso, Florent Soubrier

From the Institut National de la Santé et de la Recherche Médicale, Unit 525, Faculté de Médecine Pitié-Sapétrière, Paris, France.

Correspondence to Florent Soubrier, INSERM U525, Faculté de Médecine Pitié-Salpétrière-6e Étage, 91, Boulevard de l’Hôpital, 75013 Paris, France. E-mail florent.soubrier{at}chups.jussieu.fr

Angiotensin-converting enzyme (ACE) is an enzyme that plays a major role in vasoactive peptide metabolism, and it has been implicated in various cardiovascular diseases. Phorbol 12-myristate 13-acetate (PMA), a protein kinase C activator, has been shown to increase ACE mRNA at the transcriptional level in human umbilical vein endothelial cells. We have investigated the transcriptional mechanism involved in protein kinase C induction of the ACE gene. Deletion and transfection analyses have revealed that two regions are required for PMA-inducible gene expression. The first is a G+C-rich region located in the proximal ACE promoter bearing overlapping consensus recognition sequences for stimulatory protein-1 (Sp1) and early growth response gene 1 (Egr-1). Electrophoretic mobility shift assay and supershift experiments have shown that Egr-1 is present in the specific nucleoprotein complex induced by PMA in human umbilical vein endothelial cells. The second region is located in the distal ACE promoter. DNase I footprinting analysis restricted this region to a 21-bp element containing a cAMP-responsive element/12-O-tetradecanoylphorbol 13-acetate–responsive element sequence. Electrophoretic mobility shift assays and supershift analyses have revealed that activating protein 1 (AP-1) is the transcription factor binding the cAMP-responsive element/12-O-tetradecanoylphorbol 13-acetate–responsive element located in the ACE promoter after PMA stimulation. Mutations of either Egr-1 or AP-1 binding sites partially abrogate ACE expression induced by PMA, whereas mutation of both sites totally abrogates PMA-induced ACE expression. Treatment of cells with PD98059, a mitogen-activated protein kinase kinase-1–specific inhibitor, inhibited PMA-induced ACE expression. Our results demonstrate that the two transcription factors, Egr-1 and AP-1, are involved in the PMA-induced ACE transcriptional activation in human endothelial cells via the activation of the extracellular signal–regulated kinase 1/2 signaling pathway.


Key Words: mitogen-activated protein kinase • angiotensin-converting enzyme • transcriptional regulation • site-directed mutagenesis




This article has been cited by other articles:


Home page
HypertensionHome page
K. Kohlstedt, R. Busse, and I. Fleming
Signaling via the Angiotensin-Converting Enzyme Enhances the Expression of Cyclooxygenase-2 in Endothelial Cells
Hypertension, January 1, 2005; 45(1): 126 - 132.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. J. Ryan and C. D. Sigmund
ACE, ACE Inhibitors, and Other JNK
Circ. Res., January 9, 2004; 94(1): 1 - 3.
[Full Text] [PDF]


Home page
Circ. Res.Home page
K. Kohlstedt, R. P. Brandes, W. Muller-Esterl, R. Busse, and I. Fleming
Angiotensin-Converting Enzyme Is Involved in Outside-In Signaling in Endothelial Cells
Circ. Res., January 9, 2004; 94(1): 60 - 67.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
S. Viswanathan, B. D. Hammock, J. W. Newman, P. Meerarani, M. Toborek, and B. Hennig
Involvement of CYP 2C9 in Mediating the Proinflammatory Effects of Linoleic Acid in Vascular Endothelial Cells
J. Am. Coll. Nutr., December 1, 2003; 22(6): 502 - 510.
[Abstract] [Full Text] [PDF]